Aquestive Therapeutics Files 8-K
Ticker: AQST · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1398733
| Field | Detail |
|---|---|
| Company | Aquestive Therapeutics, Inc. (AQST) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
Related Tickers: AQST
TL;DR
AQST filed an 8-K on 6/16 for a 6/13 event - check for material updates.
AI Summary
Aquestive Therapeutics, Inc. filed an 8-K on June 16, 2025, reporting an event on June 13, 2025. The filing is primarily for Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific material events or financial figures are detailed in the provided text, which focuses on the filing's metadata.
Why It Matters
This 8-K filing indicates Aquestive Therapeutics is providing updated information to the SEC, which could include material disclosures relevant to investors.
Risk Assessment
Risk Level: low — The provided text is metadata about an 8-K filing and does not contain specific operational or financial details that would indicate immediate risk.
Key Players & Entities
- Aquestive Therapeutics, Inc. (company) — Registrant
- 0001398733 (company) — Central Index Key
- MonoSol Rx, Inc. (company) — Former Company Name
- 20250613 (date) — Date of earliest event reported
- 20250616 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for Aquestive Therapeutics?
The filing is for Regulation FD Disclosure and includes Financial Statements and Exhibits, as indicated by the form type and item information.
When was the earliest event reported in this filing?
The earliest event reported was on June 13, 2025.
What is the filing date of this 8-K?
The 8-K was filed on June 16, 2025.
What is Aquestive Therapeutics' state of incorporation?
Aquestive Therapeutics, Inc. is incorporated in Delaware.
What was Aquestive Therapeutics' former company name?
Aquestive Therapeutics, Inc.'s former company name was MonoSol Rx, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Aquestive Therapeutics, Inc. (AQST).